COP1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells

Journal of Cellular Physiology

Volumn 188, Issue 1, 2001, Pages 45-55

  Delmolino, Laurie M ^a   Stearns, Nancy A ^b   Castellot Jr , John J ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYSTEINE; EPIDERMAL GROWTH FACTOR; HEPARIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE COP1; UNCLASSIFIED DRUG; GROWTH INHIBITOR; REPRESSOR PROTEIN; WISP2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE INDUCTION; GROWTH INHIBITION; GROWTH REGULATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; AMINO ACID SEQUENCE; ANIMAL; AORTA; CELL CULTURE; CELL DIVISION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; GENE LIBRARY; GENETICS; METABOLISM; MOLECULAR GENETICS; NORTHERN BLOTTING; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; AORTA; BASE SEQUENCE; BLOTTING, NORTHERN; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENDOTHELIUM, VASCULAR; GENE LIBRARY; GROWTH INHIBITORS; HEPARIN; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; RNA, MESSENGER; SEQUENCE ALIGNMENT;

EID: 0034744034     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.1100     Document Type: Article

References (59)

1. Au YP, Kenagy RD, Clowes AW. 1992. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J Biol Chem 267:3438-3444.
2. Au YP, Dobrowolska G, Morris DR, Clowes AW. 1994. Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ Res 75:15-2.
3. Ausebel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1996. Current Protocols in Molecular Biology. New York: Wiley and Sons.
4. Bork P. 1993. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327:125-130.
5. Bornstein P. 1992. Thrombospondins: structure and regulation of expression. FASEB J 6:3290-3299.
6. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. 1991. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 14:1285-1294.
7. Brancolini C, Bottega S, Schneider C. 1992. Gas2, a growth arrest-specific protein, is a component of the microfilament network system. J Cell Biol 117:1251-1261.
8. Brigstock DR. 1999. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20:189-206.
9. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA. 1997. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272:20275-20282.
10. Caleb BL, Hardenbrook M, Cherington PV, Castellot JJ Jr. 1996. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin. J Cell Physiol 167:185-195.
11. Castellot JJ Jr., Addonizio ML, Rosenberg R, Karnovsky MJ. 1981. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol 90:372-379.
12. Castellot JJ Jr., Favreau LV, Karnovsky MJ, Rosenberg RD. 1982. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem 257:11256-11260.
13. Castellot JJ Jr., Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ. 1985. Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124:13-20.
14. Castellot JJ Jr., Pukac LA, Caleb BL, Wright TC Jr., Karnovsky MJ. 1989. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990 Mar; 110(3):863]. J Cell Biol 109:3147-3155.
15. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299.
16. Chomczynski P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
17. Ciccarella C, Philipson L, Sorrentino V. 1990. Regulation of expression of growth arrest-specific genes in mouse fibroblasts. Mol Cell Biol 10:1525-1529.
18. Clowes AW, Karnowsky MJ. 1977. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625-626.
19. Coccia EM, Cicala C, Charlesworth A, Ciccarelli C, Rossi GB, Philipson L, Sorrentino V. 1992. Regulation and expressionn of a growth arrest-specific gene (gas5.) during growth, differentiation, and development. Mol Cell Biol 12:3514-3521.
20. Del Sal G, Ruaro ME, Philipson L, Schneider C. 1992. The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70:595-607.
21. Delmolino LM, Castellot JJ. 1997. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells. J Cell Physiol 173:371-379.
22. Delmolino LM, Stearns NA, Castellot JJ Jr. 1997. Heparin induces a member of the CCN family which has characteristics of a growth arrest specific gene. Mol Biol Cell 8:287a.
23. Duguid JR, Fohwer RG, Seed B. 1988. Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc Natl Acad Sci USA 85:5738-5742.
24. Evdokiou A, Cowled PA. 1998a. Growth-regulatory activity of the growth arrest-specific gene, GAS1, in NIH3T3 fibroblasts. Exp Cell Res 240:359-367.
25. Evdokiou A, Cowled PA. 1998b. Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines. Int J Cancer 75:568-577.
26. Gonos ES. 1998. Expression of the growth arrest specific genes in rat embryonic fibroblasts undergoing senescence. Ann NY Acad Sci 851:466-469.
27. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 46:625-634.
28. Holt GD, Pangburn MK, Ginsburg V. 1990. Properdin binds to sulfatide [Gal(2-SO4)B1-1Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates. J Biol Chem 265:2852-2855.
29. Hurvitz JR, Suwairi WM, Van Hul W, El Shanti H, Superti-Furga A, Roudier J, Holderbaum D, Pauli RM, Herd JK, Van Hul EV, Rezai-Delui H, Legius E, Le Merrer M, Al Alami J, Bahabri SA, Warman ML. 1999. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 23:94-98.
30. Igarashi A, Nashiro K, Kikuchi K, Sata S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K. 1996. Connective tissue growth factor gene expression in tissue section from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-733.
31. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B. 1992. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:1021.
32. Kumar S, Hand AT, Connor JR, Dodds RA, Ryan PJ, Trill JJ, Fisher SM, Nuttall ME, Lipshutz DB, Zou C, Hwang SM, Votta BJ, James IE, Rieman DJ, Dowen M, Lee JC. 1999. Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem 274:17123-17131.
33. Lau LF, Lam SC. 1999. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248:44-57.
34. Lyons-Giordano B, Brinker JM, Kefalides NA. 1989. Heparin increases mRNA levels of thrombospondin but not fibronectin in human vascular smooth muscle cells. Biochem Biophys Res Commun 162:1100-1104.
35. Majack RA, Cook SC, Bornstein P. 1985. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol 101:1059-1070.
36. Manfioletti G, Ruaro Me, Del Sal G, Philipson L, Schneider C. 1990. A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10:2924-2930.
37. Manfioletti G, Brancolini C, Avanzi G, Schneider C. 1993. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 13:4976-4985.
38. Martinotti A, Cariani CT, Melani C, Sozzi G, Spurr NK, Pierotti MA, Colombo MP. 1992. Isolation and mapping to 17p12-13 of the human homolog of the murine growth arrest specific Gas-3 gene. Hum Mol Genet 1:331-334.
39. Mii S, Ware JA, Kent KC. 1993. Transforming growth factor-β inhibits human vascular smooth muscle cell growth and migration. Surgery 114:464-470.
40. Mishra-Gorur K, Castellot JJ. 1997. Heparin rapidly and selectively alters CAMK II phosphorylation in vascular smooth muscle cells. Mol Biol Cell 8:401a.
41. Mishra-Gorur K, Delmolino LM, Castellot JJ Jr. 1998. Biological functions of heparan sulfate and heparan sulfate proteoglycans. Trends Glycosci Glycotechnol 10:193-210.
42. Ottlinger ME, Pukac LA, Karnovsky MJ. 1993. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem 268:19173-19176.
43. Ouchi Y, Hirosumi J, Watanabe M, Hattori A, Nakamura T, Orimo H. 1988. Inhibitory effect of transforming growth factor-β on epidermal growth factor-induced proliferation of cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 157:301-307.
44. Owens GK, Geisterfer AA, Komoriya A. 1988. TGF β induced growth inhibition and cellular hypertrophy in cultured smooth muscle cells. J Cell Biol 107:771-780.
45. O'Brian TP, Yang G, Sanders L, Lau L. 1990. Expression of cyr61, a growth factor-inducible immediate early gene. Mol Cell Biol 10:3569-3577.
46. Palmer H, Libby P. 1992. Interferon-β, a potential autocrine regulator of human smooth muscle cell growth. Lab Invest 66:715-721.
47. Pukac LA, Castellot JJ Jr., Wright TC Jr., Caleb BL, Karnovsky MJ. 1990. Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regulation 1:435-443.
48. Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonnenshein GE. 1989. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 264:6990-6995.
49. Schneider C, King RM, Philipson L. 1988. Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787-793.
50. Schweinfest CW, Henderson KW, Gu J-R, Mottaridis SD, Besbeas S, Panotopoulou E, Papas TS. 1990. subtractive hybridization cDNA libraries from colon carcinoma and human cancer. Genet Anal Tech Appl 7:64-70.
51. Simmons DL, Levy DB, Yannoni Y, Erikson RL. 1989. Identification of a phorbol ester-repressible v-src-inducible gene. Proc Natl Acad Sci USA 86:1178-1182.
52. Smith RC, Wills KN, Antelman D, Perlman H, Truong LN, Krasinksi K, Walsh K. 1997. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retino-blastoma protein inhibit myocyte proliferation and neotima formation, Circulation 96:1899-1905.
53. Snow AD, Bolender RP, Wight TN, Clowes AW. 1990. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 137:313-330.
54. Stephan D, San H, Yang ZY, Gordon D, Goelz S, Nabel GJ, Nabel EG. 1997. Inhibition of vascular smooth muscle cell proliferation and intimai hyperplasia by gene transfer of beta-interferon. Mol Med 3:593-599.
55. Vacha SJ, Bennett GD, Mackler SA, Koebbe MJ, Finnell RH. 1997. Identification of a growth arrest specific (gas 5) gene by differential display as a candidate gene for determining susceptibility to hyperthermia-induced exencephaly in mice. Dev Genet 21:212-222.
56. Vadiveloo PK, Filonzi EL, Stanton H, Hamilton JA. 1997. Gl phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Atherosclerosis 133:61-69.
57. Weiser MCM, Grieshaber NA, Schwartz PE, Majack RA. 1997. Perlecan regulates Oct-1 gene expression in vascular smooth cells. Mol Biol Cell 8:999-1011.
58. Whitmore SA, Settasatian C. Crawford J, Lower KM, McCallum B, Seshadri R, Cornelisse CJ, Moreland EW, Cleton-Jansen AM, Tipping AJ, Mathew CG, Savnio M, Savoia A, Verlander P, Auerbach AD, Van Berkel C, Pronk JC, Doggett NA, Callen DF. 1998. Characterization and screening for mutation of the growth arrest-specific 11 (GAS11) and C16 or f3 genes at 16q24.3 in breast cancer. Genomics 52:325-331.
59. Zhang R, Averboukh L, Zhu W, Zhang H, Jo H, Dempsey PJ, Coffey RJ, Pardee AB, Liang P. 1998. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol 18:6131-6141.